Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Now Rated “Moderate Buy” by Sell-Side Brokerages

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the company, Marketbeat reports. Seven equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $21.50.

Several research analysts have recently issued reports on SBRA shares. Huntington started coverage on Sabra Healthcare REIT in a research report on Thursday, September 10th. They set an “outperform” rating and a $23.00 price objective for the company. Mizuho set a $21.00 target price on Sabra Healthcare REIT in a research report on Monday, August 31st. Weiss Ratings cut Sabra Healthcare REIT from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Barclays lowered their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an “equal weight” rating for the company in a report on Tuesday, October 13th. Finally, Robert W. Baird upped their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a report on Monday, August 31st.

Insider Activity

In other news, CEO Richard Matros sold 200,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the completion of the transaction, the chief executive officer owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This represents a 10.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.09% of the company’s stock.

Institutional Investors Weigh In On Sabra Healthcare REIT

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Versant Capital Management Inc boosted its stake in Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after acquiring an additional 603 shares in the last quarter. Root Financial Partners LLC purchased a new position in shares of Sabra Healthcare REIT during the third quarter worth about $34,000. Mather Group LLC. grew its holdings in shares of Sabra Healthcare REIT by 34,550.0% during the third quarter. Mather Group LLC. now owns 2,772 shares of the real estate investment trust’s stock worth $55,000 after purchasing an additional 2,764 shares during the last quarter. Integrated Wealth Concepts LLC purchased a new position in shares of Sabra Healthcare REIT during the second quarter worth about $61,000. Finally, Ameritas Advisory Services LLC purchased a new position in shares of Sabra Healthcare REIT during the second quarter worth about $82,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Stock Performance

Shares of SBRA stock opened at $19.78 on Tuesday. The company has a current ratio of 3.07, a quick ratio of 3.07 and a debt-to-equity ratio of 0.95. The firm has a fifty day moving average price of $19.95 and a 200 day moving average price of $19.96. The company has a market cap of $5.05 billion, a P/E ratio of 76.08, a PEG ratio of 1.78 and a beta of 0.63. Sabra Healthcare REIT has a 12 month low of $17.17 and a 12 month high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) EPS for the quarter, missing the consensus estimate of $0.17 by ($0.27). Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business had revenue of $230.11 million during the quarter, compared to analysts’ expectations of $219.39 million. During the same period last year, the company earned $0.38 EPS. The business’s quarterly revenue was up 24.7% compared to the same quarter last year. Sell-side analysts predict that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. The ex-dividend date was Friday, August 14th. Sabra Healthcare REIT’s payout ratio is currently 461.54%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.